Academic literature on the topic 'Adenosine receptors, A1, A2B'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Adenosine receptors, A1, A2B.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Adenosine receptors, A1, A2B"
Dubey, Raghvendra K., Delbert G. Gillespie, and Edwin K. Jackson. "A2B Adenosine Receptors Mediate the Anti-Mitogenic Effects of Adenosine in Cardiac Fibroblasts." Hypertension 36, suppl_1 (October 2000): 708. http://dx.doi.org/10.1161/hyp.36.suppl_1.708-b.
Full textBorgland, Stephanie L., Maria Castañón, Walter Spevak, and Fiona E. Parkinson. "Effects of propentofylline on adenosine receptor activity in Chinese hamster ovary cell lines transfected with human A1, A2A, or A2B receptors and a luciferase reporter gene." Canadian Journal of Physiology and Pharmacology 76, no. 12 (December 1, 1998): 1132–38. http://dx.doi.org/10.1139/y98-143.
Full textWolska, Nina, and Marcin Rozalski. "Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy." International Journal of Molecular Sciences 20, no. 21 (November 3, 2019): 5475. http://dx.doi.org/10.3390/ijms20215475.
Full textFeng, Ming-Guo, and L. Gabriel Navar. "Afferent arteriolar vasodilator effect of adenosine predominantly involves adenosine A2B receptor activation." American Journal of Physiology-Renal Physiology 299, no. 2 (August 2010): F310—F315. http://dx.doi.org/10.1152/ajprenal.00149.2010.
Full textZhan, Enbo, Victoria J. McIntosh, and Robert D. Lasley. "Adenosine A2A and A2B receptors are both required for adenosine A1 receptor-mediated cardioprotection." American Journal of Physiology-Heart and Circulatory Physiology 301, no. 3 (September 2011): H1183—H1189. http://dx.doi.org/10.1152/ajpheart.00264.2011.
Full textDarlington, Daniel N., Xiaowu Wu, Kevin L. Chang, James Bynum, and Andrew P. Cap. "Regulation of Platelet Function By Adenosine Receptors." Blood 134, Supplement_1 (November 13, 2019): 2348. http://dx.doi.org/10.1182/blood-2019-131129.
Full textMarquardt, D. L., L. L. Walker, and S. Heinemann. "Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells." Journal of Immunology 152, no. 9 (May 1, 1994): 4508–15. http://dx.doi.org/10.4049/jimmunol.152.9.4508.
Full textRees, D. A., M. D. Lewis, B. M. Lewis, P. J. Smith, M. F. Scanlon, and J. Ham. "Adenosine-Regulated Cell Proliferation in Pituitary Folliculostellate and Endocrine Cells: Differential Roles for the A1 and A2B Adenosine Receptors." Endocrinology 143, no. 6 (June 1, 2002): 2427–36. http://dx.doi.org/10.1210/endo.143.6.8837.
Full textKreisberg, M. S., E. P. Silldorff, and T. L. Pallone. "Localization of adenosine-receptor subtype mRNA in rat outer medullary descending vasa recta by RT-PCR." American Journal of Physiology-Heart and Circulatory Physiology 272, no. 3 (March 1, 1997): H1231—H1238. http://dx.doi.org/10.1152/ajpheart.1997.272.3.h1231.
Full textGebremedhin, Debebe, Brian Weinberger, David Lourim, and David R. Harder. "Adenosine Can Mediate its Actions through Generation of Reactive Oxygen Species." Journal of Cerebral Blood Flow & Metabolism 30, no. 10 (June 9, 2010): 1777–90. http://dx.doi.org/10.1038/jcbfm.2010.70.
Full textDissertations / Theses on the topic "Adenosine receptors, A1, A2B"
Halldner, Henriksson Linda. "Physiology and pathophysiology of central adenosine A1 and A2A receptors /." Stockholm, 2003. http://diss.kib.ki.se/2003/91-628-5732-0/.
Full textBANGALORE, REVANNA CHANDRASHEKAR. "Ischemia/Reperfusion injury on mice steatotic Hapatocites and differential effect of adenosine A2A and A1 receptors stimulation." Doctoral thesis, Università del Piemonte Orientale, 2016. http://hdl.handle.net/11579/115194.
Full textStumpf, Anette D. [Verfasser], and Carsten [Gutachter] Hoffmann. "Development of fluorescent FRET receptor sensors for investigation of conformational changes in adenosine A1 and A2A receptors / Anette D. Stumpf. Gutachter: Carsten Hoffmann." Würzburg : Universität Würzburg, 2016. http://d-nb.info/1111887357/34.
Full textTikh, Eugene I. "Regulation of Contractility by Adenosine A1 and A2A Receptors in the Murine Heart: Role of Protein Phosphatase 2A: A Dissertation." eScholarship@UMMS, 2006. https://escholarship.umassmed.edu/gsbs_diss/130.
Full textPagnussat, Natália. "O envolvimento dos receptores de adenosina A1 e A2A na memória em camundongos machos adultos." reponame:Biblioteca Digital de Teses e Dissertações da UFRGS, 2015. http://hdl.handle.net/10183/131897.
Full textCaffeine, a non-selective adenosine receptor antagonist, prevents memory deficits, an effect mimicked by adenosine A2A receptor (A2AR), but not receptor A1 (A1R), antagonists upon aging and Alzheimer´s disease. We tested if A2AR were also necessary for the memory impairment upon direct perturbation of the cholinergic system with scopolamine and if A2AR activation was sufficient to trigger memory deficits in naive mice using 3 tests, to probe for short-term memory, namely the object recognition task, inhibitory avoidance and modified Y-maze. The intra-peritoneal (i.p.) administration of scopolamine (1.0 mg/kg) impaired short-term memory performance in 3 tests, namely the object recognition task, inhibitory avoidance and modified Y-maze. The scopolamine-induced amnesia was prevented by the A2AR (SCH 58261, 0.5 mg/kg, i.p.) as well as by A1R antagonist (DPCPX, 1 mg/kg, i.p.) in all tests, except for the modified Y-maze, and both antagonists were devoid of effects on memory or locomotion in naive rats. Notably, the activation of A2AR with CGS 21680 (0.1 mg/kg, i.p.) before the training session was sufficient to trigger memory impairment in the 3 tests in naive mice, and effect prevented by SCH 58261 (0.5 mg/kg, i.p.). Furthermore, the intracerebroventricular administration of CGS 21680 (50 nmol) also impaired recognition memory in the object recognition task. These results show that A2AR are necessary and sufficient to trigger memory impairment and they further suggest that A1R might also be selectively engaged to control the cholinergic driven memory impairment.
Sorrentino, Claudia. "Role of CD73 - A2A/A2B receptors axis in cancer." Doctoral thesis, Universita degli studi di Salerno, 2018. http://hdl.handle.net/10556/3116.
Full textThe adenosinergic pathway plays a critical role in cancer development and progression, as well as in drug resistance to chemotherapy and/or targeted-therapy. The goal of this PhD thesis was to investigate and fully characterize the role of CD73/adenosine A2A-A2B receptors axis in cancer, highlighting the therapeutic potential of inhibitors of the adenosinergic pathway. We firstly characterized the mechanism/s by which A2BR promotes immunosuppression and angiogenesis in tumor-bearing hosts, focusing on the role of myeloid-derived suppressor cells (MDSCs) and cancer-associated fibroblasts (CAFs). The results revealed that treatment of melanoma-bearing mice with Bay60-6583, a selective A2BR agonist, is associated with 1. increased tumor VEGF-A expression and vessel density, and 2. increased accumulation of tumor-infiltrating CD11b+Gr1+cells (MDSCs). MDSCs strongly contribute to the immunosuppressive and angiogenic effects of Bay60-6583. Melanoma-bearing mice treated with a selective A2BR antagonist PSB1115 showed reduced tumor growth compared to controls and this effect was associated with reduced tumor angiogenesis, low levels of MDSCs and increased number of tumor-infiltrating CD8+ T cells. Furthermore, blockade of A2BR increased the anti-tumor effects of VEGF-A inhibitors. Next, we verified that A2BR activation also drives fibroblasts activation within melanoma tissues, by increasing the number of FAP positive cells within tumor lesions. FAP is a common marker of activated fibroblasts also named cancer-associated fibroblasts. These cells produce and secrete various tumor-promoting factors, including fibroblast growth factor (FGF)-2 and CXCL12 or stromal-derived factor 1 α (SDF1α), that were increased both in melanoma tissue and fibroblasts isolated from melanoma tissue or from skin upon Bay60-6583 treatment. Bay60-6583-induced FGF-2 from fibroblasts contributed to melanoma cells proliferation. The CXCL12/CXCR4 pathway, instead, was involved in the pro-angiogenic effects of A2BR agonist, but not in its immunosuppressive effects. These effects were significantly blocked by the A2BR antagonists PSB1115. Taken together, these data elucidate the pivotal role of A2BR in establishing a positive cross-talk between tumor-infiltrating immune cells, fibroblasts and endothelial cells that sustain tumor growth, reinforcing the therapeutic potential of A2BR blockers for cancer therapy. ... [edited by Author]
XXX ciclo
Hamil, Nicola Elizabeth. "The neuromodulatory role of adenosine A1 receptors in status epilepticus." Thesis, St George's, University of London, 2010. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.526032.
Full textWu, Weiping. "The role of adenosine and its receptor subtypes in nociception and neuropathic pain /." Stockholm, 2005. http://diss.kib.ki.se/2005/91-7140-298-5/.
Full textFinlayson, Keith. "Pharmacology and modulation of adenosine A1 receptors in the mammalian central nervous system." Thesis, University of Edinburgh, 1998. http://hdl.handle.net/1842/21241.
Full textMurphy, Cody. "Transregulation of Cardiac Ischaemic Tolerance and Stress Kinase Signalling by A1 Adenosine and ¿-Opioid Receptors." Thesis, Griffith University, 2018. http://hdl.handle.net/10072/382690.
Full textThesis (Masters)
Master of Medical Research (MMedRes)
School of Medical Science
Griffith Health
Full Text
Books on the topic "Adenosine receptors, A1, A2B"
Blythe, Louise Jane. Analysis of presynaptic metabotropic glutamate and adenosine A1 receptors. Ottawa: National Library of Canada, 1998.
Find full textBook chapters on the topic "Adenosine receptors, A1, A2B"
IJzerman, Ad P., Nora M. van der Wenden, Philip J. M. van Galen, and Ken A. Jacobson. "Molecular Modeling of Adenosine A1 and A2a Receptors." In Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology, 27–37. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-2011-5_4.
Full textMüller, Christa E., Younis Baqi, Sonja Hinz, and Vigneshwaran Namasivayam. "Medicinal Chemistry of A2B Adenosine Receptors." In The Adenosine Receptors, 137–68. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-90808-3_6.
Full textScherrmann, Jean-Michel, Kim Wolff, Christine A. Franco, Marc N. Potenza, Tayfun Uzbay, Lisiane Bizarro, David C. S. Roberts, et al. "Adenosine A1 Receptors." In Encyclopedia of Psychopharmacology, 28–29. Berlin, Heidelberg: Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_1102.
Full textTrivedi, Bharat K., Alexander J. Bridges, and Robert F. Bruns. "Structure-Activity Relationships of Adenosine A1 and A2 Receptors." In Adenosine and Adenosine Receptors, 57–103. Totowa, NJ: Humana Press, 1990. http://dx.doi.org/10.1007/978-1-4612-4504-9_3.
Full textKalla, Rao V., Jeff Zablocki, Mojgan Aghazadeh Tabrizi, and Pier Giovanni Baraldi. "Recent Developments in A2B Adenosine Receptor Ligands." In Adenosine Receptors in Health and Disease, 99–122. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-89615-9_4.
Full textGao, Zhan-Guo, Dilip K. Tosh, Shanu Jain, Jinha Yu, Rama R. Suresh, and Kenneth A. Jacobson. "A1 Adenosine Receptor Agonists, Antagonists, and Allosteric Modulators." In The Adenosine Receptors, 59–89. Cham: Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-90808-3_4.
Full textHoppe, Edmund, and Martin J. Lohse. "Desensitization of A1 Adenosine Receptors." In Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology, 133–38. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4615-2011-5_16.
Full textMartini, C., L. Trincavelli, M. Fiorini, F. Salvetti, U. Montali, A. Falleni, V. Gremigni, and A. Lucacchini. "A1 Adenosine Receptors in Human Neutrophils." In Advances in Experimental Medicine and Biology, 107–11. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5381-6_21.
Full textKiesman, William F., Elfatih Elzein, and Jeff Zablocki. "A1 Adenosine Receptor Antagonists, Agonists, and Allosteric Enhancers." In Adenosine Receptors in Health and Disease, 25–58. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-89615-9_2.
Full textDhalla, Arvinder K., Jeffrey W. Chisholm, Gerald M. Reaven, and Luiz Belardinelli. "A1 Adenosine Receptor: Role in Diabetes and Obesity." In Adenosine Receptors in Health and Disease, 271–95. Berlin, Heidelberg: Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-89615-9_9.
Full textConference papers on the topic "Adenosine receptors, A1, A2B"
Lin, Juqiang, Yating Lin, Yiming Huang, Zhiwei Wu, Jianshu Xu, Ya Hu, and Shusen Xie. "Quantitative FRET measurement of the interaction of A1 adenosine receptors and A2A adenosine receptors in living cell." In Optics in Health Care and Biomedical Optics VIII, edited by Qingming Luo, Xingde Li, Yuguo Tang, and Ying Gu. SPIE, 2018. http://dx.doi.org/10.1117/12.2500692.
Full textJang, Sunyoung, Seunah Jun, Hosun Lee, Yongtaek Lee, Joo-Yun Byun, Junghwa Park, Yu-Yon Kim, Young Gil Ahn, YoungHoon Kim, and Kwee Hyun Suh. "Abstract 1704: Discovery and characterization of a novel triple A1/A2a/A2b adenosine receptor antagonist for cancer immunotherapy." In Proceedings: AACR Annual Meeting 2021; April 10-15, 2021 and May 17-21, 2021; Philadelphia, PA. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.am2021-1704.
Full textUmapathy, Nagavedi S., Elzbieta Kaczmarek, Rudolf Lucas, Kurt Stenmark, Alexander D. Verin, and Evgenia Gerasimovskaya. "Adenosine A1 Receptors Mediated Enhancement Of Barrier Function In Vasa Vasorum Endothelial Cells." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a1872.
Full textGerasimovskaya, E. V., V. Karoor, D. Strassheim, R. Batori, A. Kovacs-Kasa, T. Sullivan, R. Moldovan, D. Klemm, A. Verin, and K. R. Stenmark. "HDAC Inhibitor Butyrate Cooperates with A1 and A2B Receptors to Attenuate Pulmonary Artery Vasa Vasorum Dysfunction in Hypoxia." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a6365.
Full textAbd. Aziz, N. A. W., R. Agarwal, A. Abd Latiff, and N. M. Ismail. "RESVERATROL AS A POTENTIAL AGENT FOR NEUROPROTECTION AGAINST INTRACEREBRAL HEMORRHAGE: INSIGHT ON THE ROLE OF ADENOSINE A1 RECEPTORS." In MedChem-Russia 2021. 5-я Российская конференция по медицинской химии с международным участием «МедХим-Россия 2021». Издательство Волгоградского государственного медицинского университета, 2021. http://dx.doi.org/10.19163/medchemrussia2021-2021-88.
Full text